Navigating and Advancing Market Access for In Vitro Diagnostics: Understanding the Roles of Key Stakeholders and Policy
-
By
-
Brandon K Hill
-
Andrea M Prinzi
-
J R Kane
-
Amalia K Corby
-
Barbara D Powe
-
October 22, 2025
-
0 min
Top Institutions in Infectious Disease
Brief introduction explaining scope and methodology.
-
#1
Johns Hopkins University
Baltimore, MD
Key Differentiators
- Infectious Diseases
- Health Policy
- Clinical Microbiology
- Diagnostic Innovation
-
#2
Mayo Clinic
Rochester, MN
Key Differentiators
- Clinical Microbiology
- Infectious Diseases
- Health Economics
- Diagnostic Innovation
-
#3
Massachusetts General Hospital / Harvard Medical School
Boston, MA
Key Differentiators
- Infectious Diseases
- Health Policy
- Clinical Microbiology
- Regulatory Science
-
#4
Centers for Disease Control and Prevention (CDC)
Atlanta, GA
Key Differentiators
- Public Health
- Infectious Diseases Diagnostics
- Health Policy
- Antimicrobial Stewardship
-
#5
University of California, San Francisco (UCSF)
San Francisco, CA
Key Differentiators
- Infectious Diseases
- Health Policy
- Clinical Microbiology
- Diagnostic Innovation
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.